Physician profile
Maude Carmel
NPI 1770871667
$3,120.05
in general payments reported to CMS, 2019-2025
17 companies · $345 in 2025
The $345 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $318 · 2020: $31.79 · 2021: $303 · 2022: $588 · 2023: $774 · 2024: $760 · 2025: $345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,880.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,879.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,900.24 | 2021-2025 | Interstim |
| Urovant Sciences INC | $240.52 | 2021-2022 | |
| Allergan, INC. | $142.26 | 2019 | |
| Medtronic USA, INC. | $139.40 | 2019-2020 | |
| C. R. Bard, INC. & Subsidiaries | $128.05 | 2023-2024 | Bard Urinary Drainage Bag |
| Boston Scientific Corporation | $104.60 | 2021-2023 | |
| Sumitomo Pharma America, INC. | $84.70 | 2023-2024 | Gemtesa |
| Becton, Dickinson and Company | $77.98 | 2025 | |
| Caldera Medical, INC | $56.49 | 2021-2022 | |
| Abbvie INC. | $56.09 | 2024 | |
| Conmed Corporation | $50.00 | 2019 | |
| Bluewind Medical | $40.31 | 2024 | Revi |
| Antares Pharma, INC. | $25.50 | 2021-2024 | Xyosted |
| Innovation Technologies INC | $24.66 | 2024 | Irrisept |
| 180 Medical, INC. | $18.11 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $16.90 | 2022 | |
| Coloplast Corp | $14.24 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maude Carmel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.